Key terms
About TLSA
Tiziana Life Sciences Ltd. is a clinical-stage biotechnology company, which engages in the research and development of biotechnological and pharmaceutical products. It specializes in developing transformative therapies for neurodegenerative and lung diseases. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest TLSA news
Mar 05
7:01am ET
Tiziana Life Sciences to present at AD/PD of nasal anti-CD3 in Alzheimer’s
Jan 08
7:53am ET
Tiziana Life Sciences announces updated clinical, PET scan findings
Jan 05
7:02am ET
Tiziana Life files new patent application related to GLP-1ra, foralumab
Dec 19
7:06am ET
Tiziana Life doses first patient in Phase 2a trial of intranasal foralumab
No recent news articles are available for TLSA
No recent press releases are available for TLSA
TLSA Financials
Key terms
Ad Feedback
TLSA Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
TLSA Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range